Why the study?
Does the severity of coronary artery disease or completeness of revascularization impact clinical outcomes in patients undergoing TAVR?
Does the severity of coronary artery disease or completeness of revascularization impact clinical outcomes in patients undergoing TAVR?
Answers are grounded in this paper and cite their sources.
The severity of concurrent coronary artery disease and the completeness of prior revascularization do not significantly affect 30-day or 1-year clinical outcomes in patients undergoing TAVR.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Paradis et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: